Locoregional Resection in Stage IV Breast Cancer: Tumor Biology, Molecular and Clinical Perspectives

Surgical Clinics of North America

Volumn 87, Issue 2, 2007, Pages 527-538

  Lang, Julie E ^a   Babiera, Gildy V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL STUDY; DORMANCY; HUMAN; KNOWLEDGE; LOCAL THERAPY; METASTASIS; MOLECULAR BIOLOGY; MULTIMODALITY CANCER THERAPY; NONHUMAN; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; THEORY;

BIOLOGY; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MOLECULAR BIOLOGY; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; SURVIVAL RATE;

EID: 34247873011     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2007.01.001     Document Type: Review

References (27)

1. Haagensen C., and Stout A. Carcinoma of the breast: criteria of inoperability. Am Surg 118 (1943) 859
2. Fisher B., Wolmark N., Redmond C., et al. Findings from NSABP protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 48 8 (1981) 1863-1872
3. Gervasoni Jr. J.E., Taneja C., Chung M.A., et al. Axillary dissection in the context of the biology of lymph node metastases. Am J Surg 180 4 (2000) 278-283
4. Krag D.N., and Single R.M. Breast cancer survival according to number of nodes removed. Ann Surg Oncol 10 10 (2003) 1152-1159
5. Singletary S.E., Walsh G., Vauthey J.N., et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8 3 (2003) 241-251
6. Weigelt B., Peterse J.L., and van 't Veer L.J. Breast cancer metastasis: markers and models. Nat Rev Cancer 5 8 (2005) 591-602
7. Schmidt-Kittler O., Ragg T., Daskalakis A., et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 100 13 (2003) 7737-7742
8. Braun S., Vogl F.D., Naume B., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353 8 (2005) 793-802
9. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 19 (2001) 10869-10874
10. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 25 (2002) 1999-2009
11. Al-Hajj M., and Clarke M.F. Self-renewal and solid tumor stem cells. Oncogene 23 43 (2004) 7274-7282
12. Al-Hajj M., Wicha M.S., Benito-Hernandez A., et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100 7 (2003) 3983-3988
13. Pardoll D. Does the immune system see tumors as foreign or self?. Annu Rev Immunol 21 (2003) 807-839
14. Danna E.A., Sinha P., Gilbert M., et al. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 64 6 (2004) 2205-2211
15. Campbell M.J., Scott J., Maecker H.T., et al. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat 91 2 (2005) 163-171
16. Karrison T.G., Ferguson D.J., and Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 91 1 (1999) 80-85
17. Demicheli R., Retsky M.W., Swartzendruber D.E., et al. Proposal for a new model of breast cancer metastatic development. Ann Oncol 8 11 (1997) 1075-1080
18. Baum M., Demicheli R., Hrushesky W., et al. Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases?. Eur J Cancer 41 4 (2005) 508-515
19. Andre F., Slimane K., Bachelot T., et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22 16 (2004) 3302-3308
20. Giordano S.H., Buzdar A.U., Smith T.L., et al. Is breast cancer survival improving?. Cancer 100 1 (2004) 44-52
21. Hortobagyi G.N. Can we cure limited metastatic breast cancer?. [comment]. J Clin Oncol 20 3 (2002) 620-623
22. Greenberg P.A., Hortobagyi G.N., Smith T.L., et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14 8 (1996) 2197-2205
23. Rivera E., Holmes F.A., Buzdar A.U., et al. Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with Stage IV breast cancer with no evidence of disease. Breast J 8 1 (2002) 2-9
24. Khan S.A., Stewart A.K., and Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer?. Surgery 132 4 (2002) 620-626 [discussion: 6-7]
25. Carmichael A.R., Anderson E.D., Chetty U., et al. Does local surgery have a role in the management of Stage IV breast cancer?. Eur J Surg Oncol 29 1 (2003) 17-19
26. Rapiti E., Verkooijen H.M., Vlastos G., et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24 18 (2006) 2743-2749
27. Babiera G.V., Rao R., Feng L., et al. Effect of primary tumor extirpation in breast cancer patients who present with Stage IV disease and an intact primary tumor. Ann Surg Oncol 13 6 (2006) 776-782